Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Rheumatoid purpura].

P Niaudet1

  • 1Service de néphrologie pédiatrique Fédération de pédiatrie Hôpital Necker-Enfants malades 75743 Paris.

La Revue Du Praticien
|April 2, 2002
PubMed
Summary
This summary is machine-generated.

Schönlein-Henoch purpura, a condition causing skin, joint, and abdominal pain, frequently involves the kidneys. Early corticosteroid treatment is crucial for severe cases to prevent long-term kidney damage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal transplantation in 4 patients with methylmalonic aciduria: a cell therapy for metabolic disease.

Molecular genetics and metabolism·2013
Same author

[Children and adolescents with ESRD].

Nephrologie & therapeutique·2012
Same author

Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients.

Clinical pharmacology and therapeutics·2009
Same author

Causes of death in pediatric systemic lupus erythematosus.

Clinical and experimental rheumatology·2009
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Area of Science:

  • Nephrology
  • Pediatric Rheumatology
  • Immunology

Background:

  • Schönlein-Henoch purpura (SHP) is a systemic vasculitis affecting small vessels.
  • It commonly presents with purpura, arthralgia, and abdominal pain, with renal involvement occurring in 33-50% of cases.
  • Renal manifestations range from microscopic hematuria and proteinuria to nephrotic syndrome and decreased renal function.

Purpose of the Study:

  • To summarize the clinical presentation, renal involvement, diagnostic methods, and treatment strategies for Schönlein-Henoch purpura.
  • To highlight the importance of early diagnosis and intervention for favorable renal outcomes.

Main Methods:

  • Review of clinical features, diagnostic criteria, and pathological findings in Schönlein-Henoch purpura.
  • Analysis of treatment approaches, particularly the role of corticosteroids in managing severe renal disease.

Related Experiment Videos

Main Results:

  • Renal disease in SHP is characterized by glomerular involvement, manifesting as hematuria and proteinuria.
  • Renal biopsy reveals mesangial proliferation and IgA deposits, with extracapillary proliferation in severe cases.
  • Early treatment with corticosteroids, such as methylprednisolone pulses, is recommended before fibrous crescent formation.

Conclusions:

  • Schönlein-Henoch purpura necessitates prompt recognition and management, especially concerning renal complications.
  • Timely intervention with corticosteroids can mitigate the risk of progressive kidney damage and improve long-term prognosis.
  • Understanding the spectrum of renal pathology in SHP guides therapeutic decisions and patient management.